A description of warfarin and new oral anticoagulant utilization patterns including initiation, switching, and discontinuation: Phase 3 of the BI/BWH Pradaxa study program (Anticoagulant utilization pattern) First published 16/04/2013 Last updated 01/04/2024 EU PAS number:EUPAS3064 Study Finalised